183 related articles for article (PubMed ID: 26025680)
41. Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate.
Joseph J; Wajapeyee N; Somasundaram K
Int J Cancer; 2005 May; 115(1):11-8. PubMed ID: 15688418
[TBL] [Abstract][Full Text] [Related]
42. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
[TBL] [Abstract][Full Text] [Related]
43. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.
Giono LE; Manfredi JJ
Mol Cell Biol; 2007 Jun; 27(11):4166-78. PubMed ID: 17371838
[TBL] [Abstract][Full Text] [Related]
44. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
[TBL] [Abstract][Full Text] [Related]
45. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of HIV early replication by the p53 and its downstream gene p21.
Shi B; Sharifi HJ; DiGrigoli S; Kinnetz M; Mellon K; Hu W; de Noronha CMC
Virol J; 2018 Mar; 15(1):53. PubMed ID: 29587790
[TBL] [Abstract][Full Text] [Related]
47. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
Devlin HL; Mack PC; Burich RA; Gumerlock PH; Kung HJ; Mudryj M; deVere White RW
Mol Cancer Res; 2008 May; 6(5):808-18. PubMed ID: 18505925
[TBL] [Abstract][Full Text] [Related]
48. Role of p53 in the progression from ochratoxin A-induced DNA damage to gene mutations in the kidneys of mice.
Kuroda K; Hibi D; Ishii Y; Yokoo Y; Takasu S; Kijima A; Matsushita K; Masumura K; Kodama Y; Yanai T; Sakai H; Nohmi T; Ogawa K; Umemura T
Toxicol Sci; 2015 Mar; 144(1):65-76. PubMed ID: 25636497
[TBL] [Abstract][Full Text] [Related]
49. Selenoprotein W depletion induces a p53- and p21-dependent delay in cell cycle progression in RWPE-1 prostate epithelial cells.
Hawkes WC; Printsev I; Alkan Z
J Cell Biochem; 2012 Jan; 113(1):61-9. PubMed ID: 21866568
[TBL] [Abstract][Full Text] [Related]
50. Transcription pattern of p53-targeted DNA repair genes in the hypoxia-tolerant subterranean mole rat Spalax.
Shams I; Malik A; Manov I; Joel A; Band M; Avivi A
J Mol Biol; 2013 Apr; 425(7):1111-8. PubMed ID: 23318952
[TBL] [Abstract][Full Text] [Related]
51. JMJD5 is a potential oncogene for colon carcinogenesis.
Zhang R; Huang Q; Li Y; Song Y; Li Y
Int J Clin Exp Pathol; 2015; 8(6):6482-9. PubMed ID: 26261525
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of histone demethylase JMJD5 promotes metastasis and indicates a poor prognosis in breast cancer.
Zhao Z; Sun C; Li F; Han J; Li X; Song Z
Int J Clin Exp Pathol; 2015; 8(9):10325-34. PubMed ID: 26617740
[TBL] [Abstract][Full Text] [Related]
53. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
54. Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction.
Tran TQ; Lowman XH; Reid MA; Mendez-Dorantes C; Pan M; Yang Y; Kong M
Oncogene; 2017 Apr; 36(14):1991-2001. PubMed ID: 27721412
[TBL] [Abstract][Full Text] [Related]
55. KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage.
Castellini L; Moon EJ; Razorenova OV; Krieg AJ; von Eyben R; Giaccia AJ
Nucleic Acids Res; 2017 Apr; 45(7):3674-3692. PubMed ID: 28073943
[TBL] [Abstract][Full Text] [Related]
56. JMJD5 cleaves monomethylated histone H3 N-tail under DNA damaging stress.
Shen J; Xiang X; Chen L; Wang H; Wu L; Sun Y; Ma L; Gu X; Liu H; Wang L; Yu YN; Shao J; Huang C; Chin YE
EMBO Rep; 2017 Dec; 18(12):2131-2143. PubMed ID: 28982940
[TBL] [Abstract][Full Text] [Related]
57. Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.
Kim TD; Oh S; Shin S; Janknecht R
PLoS One; 2012; 7(4):e34618. PubMed ID: 22514644
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
Schlereth K; Heyl C; Krampitz AM; Mernberger M; Finkernagel F; Scharfe M; Jarek M; Leich E; Rosenwald A; Stiewe T
PLoS Genet; 2013; 9(8):e1003726. PubMed ID: 23966881
[TBL] [Abstract][Full Text] [Related]
59. RRM2B-Mediated Regulation of Mitochondrial Activity and Inflammation under Oxidative Stress.
Cho EC; Kuo ML; Cheng JH; Cheng YC; Hsieh YC; Liu YR; Hsieh RH; Yen Y
Mediators Inflamm; 2015; 2015():287345. PubMed ID: 26089597
[TBL] [Abstract][Full Text] [Related]
60. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
Xue L; Zhou B; Liu X; Qiu W; Jin Z; Yen Y
Cancer Res; 2003 Mar; 63(5):980-6. PubMed ID: 12615712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
